Peter Axerio-Cilies, PhD
Research Associate
Going Viral
BIV Magazine | November 2020 How one partnership is accelerating the process of virus-focused drug development.
High Potency of a Bivalent Human Vh Domain in SARS-CoV-2 Animal Models
Li W, Schäfer A, Kulkarni SS, Liu X, Martinez DR, Chen C, Sun Z, Leist SR, Drelich A, Zhang L, Ura ML, Berezuk A, Chittori S, Leopold K, Mannar D, Srivastava SS, Zhu X, Peterson EC, Tseng CT, Mellors JW, Falzarano D, Subramaniam S, Baric RS, Dimitrov DS. Cell 183: 429-41 (2020)
John Ni, BSc
MSc Student
Jane Kong, BSc
MSc Student
COVID-19 and cryo-EM
Subramaniam S. IUCrJ 7: 575-76 (2020)
1.8 Å resolution structure of β-galactosidase with a 200 kV CRYO ARM electron microscope
Merk A, Fukumura T, Zhu X, Darling JE, Grisshammer R, Ognjenovic J, Subramaniam S. IUCrJ 7: 639-43 (2020)
IUCrJ
IUCrJ May 2020, Vol 7 No. 3 Read the abstract
The National Cryo-EM Facility at Frederick National Laboratory: Operational Procedures, Methods, and Outputs
Baxa U, Edwards TJ, Hutchison M, Wier AD, Finney J, Wang H, Subramaniam S. Microscopy Today, Cambridge University Press 28: 12–17 (2020)
UBC discovery opens new avenues for designing drugs to combat drug-resistant malaria
UBC News | Phys.org | May 1, 2020 For the first time, UBC researchers have shown a key difference in the three-dimensional structures of a key metabolic enzyme in the parasite that causes malaria compared to its human counterpart